Analyst Price Targets — INGN
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 14, 2023 1:03 pm | Mike Matson | Needham | $26.00 | $8.82 | Benzinga | Declining Sales In Challenged Oxygen Market Weighs On Inogen's Margins, Analyst Downgrades Stock |
Latest News for INGN
Inogen (INGN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
BEVERLY, Mass.--(BUSINESS WIRE)---- $INGN #AirwayClearance--Inogen Announces the Appointment of Vafa Jamali to Board of Directors.
BEVERLY, Mass.--(BUSINESS WIRE)---- $INGN #AirwayClearance--Inogen Announces Participation in the 25th Annual Needham Virtual Healthcare Conference.
BEVERLY, Mass.--(BUSINESS WIRE)---- $INGN #AirwayClearance--Inogen, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).
BEVERLY, Mass.--(BUSINESS WIRE)---- $INGN #AirwayClearance--Inogen Announces Leadership Appointments Designed to Accelerate Next Phase of Growth.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for INGN.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.